South Africa Faces Uphill Battle To Reduce HIV Infection Rates Among Young Women

medicaldaily | May 10, 2016

South Africa recorded half of the 5,000 new infections a week among young women out of 14 southern and Eastern African countries, the health minister said on Tuesday. "When it comes to the area of socio-behavioral interventions, it is an uphill battle, especially in the age group 15-24 year old girls and young women," Health Minister Aaron Motsoaledi told parliament. Interventions in South Africa, which has the world's largest HIV and Aids treatment program, has seen Aids deaths decline to 140,000 in 2014 from 320,000 in 2010, he said. The number of mother-to-child transmission of HIV has fallen significantly to less than 7,000 babies in 2015 from 70,000 babies in 2004, Motsoaledi said.

Spotlight

The goal of our project was to test insulin as a booster for cell growth and virus production. Insulin was chosen for many reasons. It is already used in cell culture, and it is approved by regulatory agencies. So this is in line with our mission to look for strategies that can be implemented quickly in industry. Insulin also is known for its anti-apoptotic and mitogenic characteristics. We expected that insulin would improve the growth profile of the cells that we work with, but its effect on virus production was unknown.

Spotlight

The goal of our project was to test insulin as a booster for cell growth and virus production. Insulin was chosen for many reasons. It is already used in cell culture, and it is approved by regulatory agencies. So this is in line with our mission to look for strategies that can be implemented quickly in industry. Insulin also is known for its anti-apoptotic and mitogenic characteristics. We expected that insulin would improve the growth profile of the cells that we work with, but its effect on virus production was unknown.

Related News

HEALTH TECHNOLOGY

Perimeter Medical Imaging AI Announces Commercial Placement of Perimeter S-Series OCT within National Healthcare Provider System

Perimeter Medical Imaging AI, Inc. | September 30, 2022

Perimeter Medical Imaging AI, Inc. announced the commercial placement of its flagship Perimeter S-Series OCT system at a hospital that is part of a major national healthcare system and one of the largest healthcare networks in North Texas. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. “This commercial placement of our Perimeter S-Series OCT system at a hospital in a major healthcare network marks a significant milestone for us as we gain traction validating our commercial model. Perimeter S-Series OCT aims to improve patient outcomes and lower healthcare costs, and we are excited that leading surgeons and hospitals are seeing the potential of our ground-breaking technology.” Jeremy Sobotta, Perimeter’s Chief Executive Officer About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level, with 10x greater image resolution than X-ray and ultrasound, and 100x greater than MRI. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company’s ticker symbol “PINK” is a reference to the pink ribbons displayed during Breast Cancer Awareness Month.

Read More

HEALTH TECHNOLOGY

Ravkoo RX Puts Consumers First With Transparent Prescription Costs

Ravkoo Health | September 27, 2022

Ravkoo Health, an innovative tech company focused on digital health, announced that its healthcare module,Ravkoo RX, will disrupt the pharmaceutical market with transparent prescription pricing. The Ravkoo Health App remotely connects registered users with doctors, therapists, and wellness coaches from the privacy of their homes. Furthermore, this comprehensive health app offers Ravkoo RX, where members can have reasonably priced prescriptions fulfilled and delivered to their doorstep. "Ravkoo RX is taking the pharmaceutical market by storm and putting the consumer first with transparent cost-plus pricing." Mayur Patel, Director of Clinical Services at Ravkoo "Everyone deserves access to affordable prescriptions, so we refused to match over-inflated costs by other pharmacies," says Patel. From your mobile device, you can consult a doctor, receive a prescription, and have it delivered to your house, creating a smooth, streamlined process with reduced barriers. Furthermore, once theRavkoo Health Appis downloaded, registered users can consult a pharmacist with any questions for free. The Ravkoo leadership team strongly felt that including pharmacist calls at no extra charge was critical. This informative service sets them apart and promotes active healthcare participation by its members. Also, Ravkoo Pharmacists can pull health records, so registered users have all their data in one place. Members can see their important medical information using different tabs, such as medication history, plan of care, and documents. At the same time, healthcare providers have more information to work with, providing consistency. About Ravkoo Health Ravkoo Health harnesses the power of technology to give people control over their health information on a secure platform. Furthermore, ravkoo Health is emerging as a one-stop-shop digital healthcare marketplace. Online members of the app can access and store health data, choose and consult with telemedicine professionals, make prescription arrangements, order at-home lab kits, receive lab results over the phone, confer with weight loss, nutrition, and wellness coaches, track fitness, and access up-to-date health information.

Read More

HEALTH TECHNOLOGY

Avail Reaches Significant Network Expansion Milestone with the Signing of its 50th MedTech Contract

Avail Medsystems | August 05, 2022

Avail, the digital hub of the operating room enabling the medical technology and healthcare industries to work smarter to advance patient care, announced the addition of a 50th MedTech organization to its telepresence network. With the signing of this contract, the Avail platform is poised to enable hundreds of thousands of people to collaborate, educate, and share surgical and MedTech expertise between operating rooms and remote locations in real time. "The Avail platform was built to connect the MedTech industry more frequently, efficiently and seamlessly to surgeons and interventionalists, enabling them to work together more closely to advance medicine. With this exciting milestone, the digital evolution of MedTech is well underway. Many of our MedTech partners are integrating Avail into their daily processes to expand the productivity and reach of their commercial teams, thus helping representatives to better engage with customers and support their success." Daniel Hawkins, CEO of Avail For some of the world's largest and most respected MedTech companies specializing in devices for neurosurgery, interventional cardiology, interventional radiology, vascular surgery, and orthopedic surgery, among others — Avail has positively changed business practices in myriad ways. These include enabling faster product training and expanded reach for field teams, dramatically increasing the time they have available to sell products and support live procedures. In addition, MedTech companies and surgeons have realized the mutual benefits of using Avail to collaborate during unplanned cases when field representatives are unable to reach remote locations to join in person. With skyrocketing travel costs and staff shortages, Avail's approach to collaboration has allowed physician education and product launch programs not only to continue, but to operate more efficiently and rapidly. Other uses include enabling the acceleration of product innovation by allowing engineering and R&D teams to better connect with providers. "As far as technology goes, the Avail experience has completely raised the bar for our Professional Education Programs — Avail makes us look good," stated John Vogrin, Senior Manager, Surgical Care Services for Cochlear Americas. "But more importantly, using Avail has allowed Cochlear to reduce travel for members of our sales team and give them back countless hours of their personal lives while improving the training experience and shortening the time it takes to complete. It's a win-win-win-win for our company, employees, customers, and their patients." Avail's footprint of consistent, purpose-built hardware in procedure rooms, along with integrated software created for that hardware, serves as the foundation of the company's surgical telepresence platform. The mobile Avail console includes edge-based computing and a large display monitor and is connected securely to the cloud to stream high-quality audio, video, and surgical imaging to remote participants in a HIPAA-HITECH protected environment. "Future-forward MedTech companies and healthcare systems not only need better, faster means of collaboration, but they want a way to share their own software capabilities to and from the OR," stated James Domine, CTO of Avail. "Avail's consistent hardware footprint provides eyes and ears into the operating room and will also enable the sharing of applicable third-party software capabilities, including AI and machine learning, which can be displayed on the large Avail console monitor to further elevate the collaborative experience. This can help improve processes and speed the adoption of new products that better meet the changing healthcare environment." News of the 50th MedTech contract follows Avail's recent announcements of another company expansion and a partnership with the Stroke Thrombectomy and Aneurysm Registry (STAR), which enables participating neurosurgeons to collaborate and share expertise, regardless of their locations. About Avail Medsystems Avail enables the MedTech industry and healthcare providers to work together more often and more efficiently, harnessing expertise and technology in and out of the OR to accelerate the innovation, adoption, and reach of tools and techniques to improve patient care. Avail does this by placing a consistent, mobile, hardware platform with integrated software into operating rooms, audibly and visually connecting remote participants and serving as the hub for advanced digital capabilities including AI and machine learning, in a secure cloud-based digital telepresence network. Today, 50 MedTech organizations have contracted with Avail to rethink commercial models, reduce inefficiencies, and enhance the reach and timeliness of collaboration. Avail was founded in 2017 by MedTech veterans with a vision to leverage Silicon Valley technology expertise to evolve the industry and enable MedTech and healthcare to deliver the best care possible. Avail.io

Read More